Form 4 for KURA Kura Oncology, Inc.
Accepted 2025-05-19 00:00:00 ET · period of report 2025-05-19 · accession 0000950170-25-074659 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-05-19 | 2025-05-19 | KURA | FORD KATHLEEN | COO | S - Sale | $6.28 | -1,558 | 21.4K | -7% | -$9,784 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-19 | S | D | 1,558 | $6.28 | 21,367 | D | — | — | (F2) 1,558 shares were acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. (F3) This transaction was executed in multiple trades at prices ranging from $6.27 to $6.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |